Table 2.
Diameter of inhibition zones of the synthesized AgNPs efficacy against different strains of pathogenic bacteria and yeast (Data were represented by mm as Mean of three replicates ± SD).
| Teste strain | Streptomycin (Standard antibacterial agent) | Fluconazole (Standard antifungal agent) | Mean of Inhibition zone diameter nm (Mean ± SD) | P-value |
|---|---|---|---|---|
| Staphylococcus aureus (MRSA) | 23 | ------ | 30.12 ± 0.54 | 0.0523* |
| Staphylococcus epidermidis | 32 | ------- | 39.0 ± 0.09 | 0.0276* |
| Klebsiella pneumoniae | 28 | -------- | 31.04 ± 1.52 | 0.0113* |
| Escherichia coli | 27 | ------ | 35.93 ± 0.26 | 0.0551* |
| Candida albicans | --------- | 22.01 | 28.41 ± 1.03 | 0.0917* |
The concentration of standard antibiotic was 200 µgml−1.
The concentration of AgNPs was 200 µgml−1.
*
p-value significant < 0.05.